Related Experiment Video

Updated: Jun 10, 2026

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
06:48

Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment

Published on: April 29, 2022

Comment on "Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple

Ugo Moens, Alexey Shiryaev, Gianina Dumitriu

    Science Signaling
    |July 22, 2010
    PubMed

    Insights

    The phosphorylation of human PRAK (p38-regulated/activated protein kinase) at Ser(93) in senescent cells is uncertain. The antibody used in a previous study is unavailable, hindering verification of this key finding.

    Area of Science:

    • Cellular senescence
    • Protein kinase regulation
    • Post-translational modifications

    Background:

    • Previous research suggested human PRAK (p38-regulated/activated protein kinase) is phosphorylated at Ser(93) in senescent cells.
    • This phosphorylation event was linked to cellular senescence pathways.

    Discussion:

    • The antibody used to detect PRAK phosphorylation at Ser(93) is no longer available.
    • Replication of the original findings has been unsuccessful with the available antibody.
    • The unavailability of the antibody raises questions about the validity of the reported Ser(93) phosphorylation in PRAK.

    Key Insights:

    • The phosphorylation status of PRAK at Ser(93) in senescent cells remains unconfirmed.
    • Methodological limitations, including antibody availability, impact the verification of cellular signaling events.
    • Further research is needed to elucidate the regulatory mechanisms of PRAK during senescence.

    Outlook:

    • Development of novel antibodies or alternative detection methods is crucial for validating PRAK phosphorylation.
    • Investigating other potential regulatory sites on PRAK may reveal alternative mechanisms of kinase activation in senescence.
    • Understanding PRAK's role in senescence is vital for potential therapeutic interventions targeting age-related diseases.

    More Related Videos

    Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

    Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

    Published on: March 30, 2019

    Techniques to Induce and Quantify Cellular Senescence06:51

    Techniques to Induce and Quantify Cellular Senescence

    Published on: May 1, 2017

    Related Concept Videos

    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
    Replicative Cell Senescence02:15

    Replicative Cell Senescence

    Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
    Replicative Cell Senescence02:15

    Replicative Cell Senescence

    Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...